Pentoxifylline effects on the treatment of non alcoholic steatohepatitis
Not Applicable
- Conditions
- non alcoholic steatohepatitis.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT2015033021565N1
- Lead Sponsor
- Kerman University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
diagnosis of non alcoholic steatohepatitis is with clinical and paraclinical criteria (elevated ALT and AST to 1.5 times more than normal and sonography confirmation of fatty liver). Exclusion criteria: Diabetes mellitus; hyperlypidemia; liver diseases(Serum level, ASMA, ANA, FERRITIN, a-1anti tripsin, people with positive markers hepaptitis B virus, hepatitis c & hepatitis a); drug users (Calsium channel blocker, B blocker, amiodarone, glucocorticoids, strogen,...); alcoholic users; people who intervened before and during acute or chronic liveror systemic disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT. Timepoint: Before the intervention, third month after intervention, sixth mounth after intervention. Method of measurement: Blood Exam.;AST. Timepoint: Before the intervention, third month after intervention, sixth mounth after intervention. Method of measurement: Blood Exam.;BMI. Timepoint: Before the intervention, third month after intervention, sixth mounth after intervention. Method of measurement: height measurement with tape and weight measurement with digital scale.;IL-6. Timepoint: Before the intervention, sixth mounth after intervention. Method of measurement: Elisa Exam.;IL-8. Timepoint: Before the intervention, sixth mounth after intervention. Method of measurement: Elisa Exam.;TNF-a. Timepoint: bBfore the intervention, sixth mounth after intervention. Method of measurement: Elisa Exam.
- Secondary Outcome Measures
Name Time Method